Sex differences in pharmacokinetics of cilostazol in rats

References

• Abbas R, Chow CP, Browder NJ, Thacker D, Bramer SL, Fu CJ, Forbes W, Odomi M, Flockhart DA. (2000). In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms. Hum Exp Toxicol 19:178–184.
   PubMed Web of Science ®Google Scholar
• Aiba T, Yoshinaga M, Ishida K, Takehara Y, Hashimoto Y. (2005). Intestinal expression and metabolic activity of the CYP3A subfamily in female rats. Biol Pharm Bull 28:311–315.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Kudo S, Shimizu T. (1985a). The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man. Arzneimittelforschung 35:1124–1132.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Kudo S, Shimizu T. (1985b). The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man. Arzneimittelforschung 35:1133–1140.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–420.
   PubMed Web of Science ®Google Scholar
• Artursson P, Palm K, Luthman K. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 46:27–43.
   PubMed Web of Science ®Google Scholar
• Asaoka Y, Sakai H, Sasaki J, Goryo M, Yanai T, Masegi T, Okada K. (2010). Changes in the gene expression and enzyme activity of hepatic cytochrome P450 in juvenile Sprague-Dawley rats. J Vet Med Sci 72:471–479.
   PubMed Web of Science ®Google Scholar
• Bramer SL, Forbes WP, Mallikaarjun S. (1999). Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease. Clin Pharmacokinet 37 Suppl 2:1–11.
   PubMedGoogle Scholar
• Brandstetter Y, Kaplanski J, Leibson V, Ben-Zvi Z. (1986). The effects of estrus cycle on drug metabolism in the rat. Eur J Drug Metab Pharmacokinet 11:251–254.
   PubMedGoogle Scholar
• Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, Shin HC, Lennernas H, Zhong Y, Amidon GL, Yu LX, Sun D. (2006). Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 23:1675–1686.
   PubMed Web of Science ®Google Scholar
• Chan S, Edwards SR, Wyse BD, Smith MT. (2008). Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat. Clin Exp Pharmacol Physiol 35:295–302.
   PubMedGoogle Scholar
• Chiou WL, Barve A. (1998). Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 15:1792–1795.
   PubMed Web of Science ®Google Scholar
• Chong S, Dando SA, Soucek KM, Morrison RA. (1996). In vitro permeability through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system. Pharm Res 13:120–123.
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–1095.
   PubMed Web of Science ®Google Scholar
• Eeckhoudt SL, Horsmans Y, Verbeeck RK. (2002). Differential induction of midazolam metabolism in the small intestine and liver by oral and intravenous dexamethasone pretreatment in rat. Xenobiotica 32:975–984.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Yamada Y, Kusama M, Yamauchi T, Kamon J, Kadowaki T, Iga T. (2003). Sex differences in the pharmacokinetics of pioglitazone in rats. Comp Biochem Physiol C Toxicol Pharmacol 136:85–94.
   PubMed Web of Science ®Google Scholar
• Galetin A, Hinton LK, Burt H, Obach RS, Houston JB. (2007). Maximal inhibition of intestinal first-pass metabolism as a pragmatic indicator of intestinal contribution to the drug-drug interactions for CYP3A4 cleared drugs. Curr Drug Metab 8:685–693.
   PubMed Web of Science ®Google Scholar
• Hanada K, Fujisawa R, Kataoka R, Nakamura S, Ogata H. (2001). Sex-related differences in the renal disposition of the acidic metabolite of clentiazem in rat. Xenobiotica 31:725–731.
   PubMed Web of Science ®Google Scholar
• Higaki K, Ishii M, Esumi H, Kanayama M, Ogawara KI, Kimura T. (2003). Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics II: Studies with isolated perfused rat liver. Xenobiotica 33:1097–1108.
   PubMed Web of Science ®Google Scholar
• Higaki K, Nakano M. (1992). Stereoselective disposition of S-8666, a novel uricosuric antihypertensive diuretic, and its N-monodemethylated metabolite in a perfused rat liver preparation. Effect of protein binding on the kinetics of S-8666. Drug Metab Dispos 20:350–355.
   PubMed Web of Science ®Google Scholar
• Higaki K, Sone M, Ogawara K, Kimura T. (2004). Regulation of drug absorption from small intestine by enteric nervous system I: a poorly absorbable drug via passive diffusion. Drug Metab Pharmacokinet 19:198–205.
   PubMedGoogle Scholar
• Hiratsuka M, Hinai Y, Sasaki T, Konno Y, Imagawa K, Ishikawa M, Mizugaki M. (2007). Characterization of human cytochrome p450 enzymes involved in the metabolism of cilostazol. Drug Metab Dispos 35:1730–1732.
   PubMed Web of Science ®Google Scholar
• Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y, Funae Y. (1996). Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem Pharmacol 51:1041–1050.
   PubMed Web of Science ®Google Scholar
• Janssen FW, Young EM, Ruelius HW. (1976). Effect of sex hormones on the disposition in rats of 1-aminocyclohexane carboxylic acid, a metabolite of semisynthetic penicillin. Drug Metab Dispos 4:540–546.
   PubMed Web of Science ®Google Scholar
• Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T. (2006). Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 111:56–64.
   PubMed Web of Science ®Google Scholar
• Kato R. (1974). Sex-related differences in drug metabolism. Drug Metab Rev 3:1–32.
   PubMed Web of Science ®Google Scholar
• Kato R, Yamazoe Y. (1992). Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol Lett 64-65 Spec No:661–667.
   PubMedGoogle Scholar
• Kato Y, Kuge K, Kusuhara H, Meier PJ, Sugiyama Y. (2002). Gender difference in the urinary excretion of organic anions in rats. J Pharmacol Exp Ther 302:483–489.
   PubMed Web of Science ®Google Scholar
• Komura H, Iwaki M. (2008). Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates. J Pharm Sci 97:1775–1800.
   PubMed Web of Science ®Google Scholar
• Kotegawa T, Laurijssens BE, Von Moltke LL, Cotreau MM, Perloff MD, Venkatakrishnan K, Warrington JS, Granda BW, Harmatz JS, Greenblatt DJ. (2002). In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat. J Pharmacol Exp Ther 302:1228–1237.
   PubMed Web of Science ®Google Scholar
• Kvetina J, Guaitani A. (1969). A versatile method for the in vitro perfusion of isolated organs of rats and mice with particular reference to liver. Pharmacology 2:65–81.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Kim HJ, Miyata M, Shimada M, Nagata K, Yamazoe Y. (2004). Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat. J Pharmacol Exp Ther 309:1282–1290.
   PubMed Web of Science ®Google Scholar
• Mihara K, Matsumura M, Yoshioka E, Hanada K, Nakasa H, Ohmori S, Kitada M, Ogata H. (2001). Intestinal first-pass metabolism of eperisone in the rat. Pharm Res 18:1131–1137.
   PubMed Web of Science ®Google Scholar
• Mortimore GE. (1961). Effect of insulin on potassium transfer in isolated rat liver. Am J Physiol 200:1315–1319.
   PubMed Web of Science ®Google Scholar
• Mugford CA, Kedderis GL. (1998). Sex-dependent metabolism of xenobiotics. Drug Metab Rev 30:441–498.
   PubMed Web of Science ®Google Scholar
• Sato M, Suzaka H, Miyazaki H. (2000). Sex-related differences in urinary excretion of egualen sodium in rats. Drug Metab Dispos 28:21–27.
   PubMedGoogle Scholar
• Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL. (2004). In vitro testing of drug absorption for drug ‘developability’ assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel 7:75–85.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Deguchi Y, Ishii I, Terai T. (1991). Sex differences in excretion of zenarestat in rat. Xenobiotica 21:1119–1125.
   PubMed Web of Science ®Google Scholar
• Terashita S, Sawamoto T, Deguchi S, Tokuma Y, Hata T. (1995). Sex-dependent and independent renal excretion of nilvadipine metabolites in rat: evidence for a sex-dependent active secretion in kidney. Xenobiotica 25:37–47.
   PubMed Web of Science ®Google Scholar
• Toyobuku H, Tamai I, Ueno K, Tsuji A. (2003). Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug. J Pharm Sci 92:2249–2259.
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Holloway MG. (2009). Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76:215–228.
   PubMed Web of Science ®Google Scholar
• Yang SH, Yang KH, Lee MG. (2008). Gender differences in ondansetron pharmacokinetics in rats. Biopharm Drug Dispos 29:406–413.
   PubMedGoogle Scholar
• Yoo HD, Cho HY, Lee YB. (2010). Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1. Br J Clin Pharmacol 69:27–37.
   PubMedGoogle Scholar